|
ZNF552 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.47349999999269E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.026700E-04 |
| Normal-vs-Stage2 |
1.435900E-02 |
| Normal-vs-Stage3 |
2.575200E-04 |
| Normal-vs-Stage4 |
2.42939999999248E-05 |
| Stage1-vs-Stage2 |
7.804800E-01 |
| Stage1-vs-Stage3 |
9.984800E-01 |
| Stage1-vs-Stage4 |
2.573600E-01 |
| Stage2-vs-Stage3 |
8.105000E-01 |
| Stage2-vs-Stage4 |
2.931200E-01 |
| Stage3-vs-Stage4 |
2.571000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.771800E-04 |
| Normal-vs-AfricanAmerican |
2.474200E-02 |
| Normal-vs-Asian |
7.224400E-03 |
| Caucasian-vs-AfricanAmerican |
8.071000E-01 |
| Caucasian-vs-Asian |
6.030600E-01 |
| AfricanAmerican-vs-Asian |
8.907200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.039370E-03 |
| Normal-vs-Female |
2.32889999999264E-05 |
| Male-vs-Female |
5.145000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.78317999999233E-05 |
| Normal-vs-Age(41-60Yrs) |
8.427400E-04 |
| Normal-vs-Age(61-80Yrs) |
4.413200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.047600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.820200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.135600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.177800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.487600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.882200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.720600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.984400E-01 |
| Classical-VS-Follicular |
7.82109999986069E-07 |
| Classical-VS-Other |
2.051000E-01 |
| Classical-VS-Normal |
5.536000E-03 |
| Tall-VS-Follicular |
3.358000E-02 |
| Tall-VS-Other |
4.005200E-01 |
| Tall-VS-Normal |
5.777600E-03 |
| Follicular-VS-Other |
7.396800E-01 |
| Follicular-VS-Normal |
1.2341999977572E-08 |
| Other-VS-Normal |
1.864190E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95189999999679E-05 |
| Normal-vs-N1 |
1.0073999999749E-06 |
| N0-vs-N1 |
2.673600E-01 |
|
|
